Surmodics, Inc. (SRDX)
NASDAQ: SRDX · IEX Real-Time Price · USD
26.65
+0.26 (0.99%)
Apr 19, 2024, 9:41 AM EDT - Market open
Surmodics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.42 | 19 | 31.15 | 30.79 | 30.36 | 23.67 | 16.53 | 24.99 | 55.59 | 43.51 | Upgrade
|
| Short-Term Investments | 3.93 | 0 | 7.72 | 30.31 | 24.93 | 41.35 | 31.8 | 21.95 | 0 | 3.04 | Upgrade
|
| Cash & Cash Equivalents | 45.35 | 19 | 38.87 | 61.1 | 55.29 | 65.02 | 48.34 | 46.94 | 55.59 | 46.55 | Upgrade
|
| Cash Growth | 138.72% | -51.12% | -36.38% | 10.50% | -14.96% | 34.52% | 2.97% | -15.56% | 19.41% | 81.08% | Upgrade
|
| Receivables | 10.85 | 10.45 | 9.17 | 7.68 | 8.99 | 8.88 | 7.21 | 6.87 | 7.48 | 4.75 | Upgrade
|
| Inventory | 14.84 | 11.82 | 6.76 | 5.97 | 4.5 | 4.02 | 3.52 | 3.58 | 2.98 | 2.82 | Upgrade
|
| Other Current Assets | 15.65 | 16.32 | 15.46 | 11.87 | 12.63 | 3.61 | 1.82 | 1.17 | 1.74 | 1.16 | Upgrade
|
| Total Current Assets | 86.69 | 57.59 | 70.26 | 86.61 | 81.42 | 81.53 | 60.88 | 58.56 | 67.79 | 55.28 | Upgrade
|
| Property, Plant & Equipment | 26.03 | 27.15 | 30.09 | 30.1 | 29.75 | 30.14 | 22.94 | 19.6 | 12.97 | 13.13 | Upgrade
|
| Long-Term Investments | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 16.82 | Upgrade
|
| Goodwill and Intangibles | 69.15 | 68.86 | 82.66 | 40.47 | 40.4 | 44.72 | 47.84 | 49.08 | 10.77 | 10.96 | Upgrade
|
| Other Long-Term Assets | 3.86 | 4.77 | 9.59 | 11.58 | 8.3 | 7.75 | 4.92 | 5.66 | 7.18 | 8.7 | Upgrade
|
| Total Long-Term Assets | 99.04 | 100.77 | 124.34 | 82.16 | 78.45 | 82.61 | 75.71 | 74.34 | 30.92 | 49.61 | Upgrade
|
| Total Assets | 185.73 | 158.36 | 194.59 | 168.76 | 159.87 | 164.14 | 136.59 | 132.89 | 98.71 | 104.89 | Upgrade
|
| Accounts Payable | 2.99 | 3.14 | 1.78 | 1.52 | 2.09 | 2.55 | 2.4 | 1.62 | 0.86 | 1.03 | Upgrade
|
| Deferred Revenue | 6.78 | 9.25 | 14.95 | 16 | 17.18 | 20.89 | 0.24 | 0 | 0.27 | 0.28 | Upgrade
|
| Current Debt | 0 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 14.18 | 9.7 | 3.08 | 1.38 | 0.94 | 11.69 | 7.16 | 8.51 | 3.58 | 2.76 | Upgrade
|
| Total Current Liabilities | 23.95 | 32.08 | 29.82 | 18.89 | 20.21 | 35.13 | 9.8 | 10.14 | 4.7 | 4.07 | Upgrade
|
| Long-Term Debt | 29.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 12.46 | 17.89 | 24.69 | 18.82 | 17.14 | 20.39 | 15.23 | 15.93 | 2.14 | 2.07 | Upgrade
|
| Total Long-Term Liabilities | 41.87 | 17.89 | 24.69 | 18.82 | 17.14 | 20.39 | 15.23 | 15.93 | 2.14 | 2.07 | Upgrade
|
| Total Liabilities | 65.82 | 49.97 | 54.51 | 37.71 | 37.35 | 55.53 | 25.04 | 26.06 | 6.84 | 6.14 | Upgrade
|
| Total Debt | 29.41 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt Growth | 194.05% | - | - | - | - | - | - | - | - | - | Upgrade
|
| Retained Earnings | 87.26 | 88.79 | 116.07 | 111.83 | 110.71 | 97.62 | 102.07 | 98.15 | 88.16 | 93.88 | Upgrade
|
| Comprehensive Income | -4.76 | -9.87 | 1.73 | 3.17 | 0.4 | 2.72 | 3.42 | 1.27 | 0.01 | 1.53 | Upgrade
|
| Shareholders' Equity | 119.91 | 108.39 | 140.09 | 131.06 | 122.52 | 108.61 | 111.56 | 106.83 | 91.87 | 98.75 | Upgrade
|
| Net Cash / Debt | 15.95 | 9 | 28.87 | 61.1 | 55.29 | 65.02 | 48.34 | 46.94 | 55.59 | 46.55 | Upgrade
|
| Net Cash / Debt Growth | 77.23% | -68.83% | -52.75% | 10.50% | -14.96% | 34.52% | 2.97% | -15.56% | 19.41% | 81.08% | Upgrade
|
| Net Cash Per Share | 1.14 | 0.65 | 2.06 | 4.42 | 4.01 | 4.94 | 3.61 | 3.55 | 4.18 | 3.35 | Upgrade
|
| Working Capital | 62.74 | 25.51 | 40.44 | 67.72 | 61.21 | 46.39 | 51.08 | 48.42 | 63.09 | 51.21 | Upgrade
|
| Book Value Per Share | 8.55 | 7.79 | 10.18 | 9.67 | 9.15 | 8.26 | 8.48 | 8.22 | 7.05 | 7.24 | Upgrade
|